Positive Patient Stories™

Paratek Investor Day Summary and Slides

Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, hosted an Investor Day on Tuesday, October 17, 2017, from 12:00 p.m. to 3:00 p.m. ET at the Lotte Palace Hotel in New York City.

During the Investor Day, Paratek’s management team and experts in the field of antibiotics development and infectious disease will discuss progress of the clinical development program and pre-commercialization activities for omadacycline.

The meeting featured presentations by key opinion leaders including:

  • George Zhanel, Ph.D., University of Manitoba
  • George Sakoulas, M.D., University of California San Diego
  • Fredrick M. Abrahamian, DO, FACEP, FIDSA, David Geffen School of Medicine at UCLA

The Investor Day webcast can be viewed here. The slides presented at Investor Day can be accessed here.




10/19/2017 12:00:00 AM

Talk with the Paratek Team

Send us an inquiry by submitting a form directly on the site or give us a call.